Glatiramer acetate (Copaxone) therapy may alter B cell function in multiple sclerosis
1. Glatiramer acetate is an immunomodulatory drug used in the treatment of multiple sclerosis. 2. Glatiramer acetate appears to alter ...
Tag: multiple sclerosis
Walk test linked to quality of life in multiple sclerosis
1. The timed 25-foot walk (T25-FW) test is a means for assessing disability due to walking impairment in multiple sclerosis. ...
HIV infection may protect against multiple sclerosis
1. In this study cohort, patients who were HIV positive had a lower risk of developing multiple sclerosis. 2. This ...
Increased multiple sclerosis relapse after natalizumab (Tysabri) discontinuation (TY-STOP Study)
1. In patients with relapsing-remitting multiple sclerosis (MS), discontinuation of natalizumab therapy was associated with increased annual relapse rate and ...
Regional central nervous damage associated with fatigue in multiple sclerosis
1. Multiple sclerosis (MS) patients with fatigue symptoms showed marked regional changes on magnetic resonance imaging (MRI) as compared to ...
Simvastatin may slow brain atrophy in secondary progressive multiple sclerosis [MS-STAT study]
Image: PD 1. High dose simvastatin therapy reduced the annual brain atrophy rate over two years compared to placebo in ...
Alcohol consumption inversely related to risk of developing Multiple Sclerosis
Image: PD 1. Swedish adults who reported the highest amount of alcohol consumption had a decreased incidence of Multiple Sclerosis ...
Interferon beta-1b for relapsing-remitting multiple sclerosis [Classics Series]
1. In patients with relapsing-remitting multiple sclerosis, treatment with interferon beta-1b significantly reduced the rate of multiple sclerosis exacerbations in ...
The TRANSFORMS trial: Fingolimod vs interferon in multiple sclerosis [Classics Series]
Image: PD 1. Fingolimod significantly reduced the number of relapses as compared to interferon beta-1a over a one-year period. 2. ...
The DEFINE trial: BG-12 reduces relapse rate in multiple sclerosis [Classics Series]
Image: PD 1. BG-12 (dimethyl fumarate) significantly reduces relapse rates, disability progression, and image detectable lesion load over a two-year ...
